References

Ironing out the role of ferroptosis in immunity

10.1016/j.immuni.2024.03.019 · 2024 · External reference

The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis

10.1038/s41586-019-1705-2 · 2019 · External reference

m(6)A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/FOXM1 positive feedback loop

10.1016/j.canlet.2024.217004 · 2024 · External reference

Writers, readers, and erasers RNA modifications and drug resistance in cancer

10.1186/s12943-024-02089-6 · 2024 · External reference

JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2 axis mediated cell ferroptosis

10.1186/s12967-025-06241-8 · 2025 · External reference

Deletion of GPX8 enhances irradiation-induced ferroptosis through m(6)A hypomethylation-mediated upregulation of ACSL4 in oral cancer

10.1177/15230864261449406 · 2026 · External reference

METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis

10.7150/ijbs.100518 · 2025 · External reference

YTHDF2-mediated stabilization of SREBF1 promotes lipid metabolic reprogramming and ferroptosis-associated radioresistance in Anaplastic thyroid carcinoma

10.1016/j.canlet.2025.218232 · 2026 · External reference

The roles and implications of RNA m(6)A modification in cancer

10.1038/s41571-023-00774-x · 2023 · External reference

Depletion of the N(6)-Methyladenosine (m6A) reader protein IGF2BP3 induces ferroptosis in glioma by modulating the expression of GPX4

10.1038/s41419-024-06486-z · 2024 · External reference

The m(6)A reader YTHDF1 promotes lung carcinoma progression via regulating ferritin mediate ferroptosis in an m(6)A-Dependent manner

10.3390/ph16020185 · 2023 · External reference

Ferroptosis: an iron-dependent form of nonapoptotic cell death

10.1016/j.cell.2012.03.042 · 2012 · External reference

ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition

10.1038/nchembio.2239 · 2017 · External reference

FSP1 is a glutathione-independent ferroptosis suppressor

10.1038/s41586-019-1707-0 · 2019 · External reference

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

10.1038/nature11112 · 2012 · External reference

M6A-ALKBH5-dependent RBMS3-AS3 down-regulation suppresses ferroptosis to promote lung adenocarcinoma progression through HNRNPDL/ZEB1/GPX4 axis

10.1038/s41698-025-01141-y · 2025 · External reference

M(6)A modification mediates CACNA1A stability to drive the progression of ovarian cancer by inhibiting ferroptosis

10.1186/s13048-025-01907-9 · 2025 · External reference

Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1

10.1016/j.intimp.2024.113804 · 2025 · External reference

Methyltransferase-like 7B participates in bladder cancer via ACSL3 m(6)A modification in a ferroptosis manner

10.1186/s13062-025-00597-z · 2025 · External reference

FTO prevents thyroid cancer progression by SLC7A11 m6A methylation in a ferroptosis-dependent manner

10.3389/fendo.2022.857765 · 2022 · External reference

N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

10.1038/nchembio.687 · 2011 · External reference

Ferroptosis: mechanisms, biology and role in disease

10.1038/s41580-020-00324-8 · 2021 · External reference

Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis

10.1038/nchembio.2238 · 2017 · External reference

Mechanism of LncRNA NORAD regulating ferroptosis in endometrial cancer cells by modifying GPX4 through FTO-Mediated m6A methylation

10.1007/s00018-025-05855-x · 2025 · External reference

GTP cyclohydrolase 1/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling

10.1021/acscentsci.9b01063 · 2020 · External reference

Targeting ferroptosis as a vulnerability in cancer

10.1038/s41568-022-00459-0 · 2022 · External reference

METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer

10.1080/15384047.2024.2349429 · External reference

Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma

10.1016/j.redox.2023.102971 · External reference

The role of RNA methylation in tumor immunity and its potential in immunotherapy

10.1186/s12943-024-02041-8 · External reference

An exosome-biomimetic photothermal nanocarrier for IGF2BP2 siRNA delivery and enhanced ferroptosis in head and neck squamous cell carcinoma

10.1016/j.mtbio.2026.102999 · External reference

m(6)A methylation dependent autophagy activation is required for anti-tumor effects of artesunate through ferroptosis in hepatocellular carcinoma

10.1016/j.cbi.2026.111950 · External reference

A METTL3-METTL14 complex mediates Mammalian nuclear RNA N6-adenosine methylation

10.1038/nchembio.1432 · 2014 · External reference

Insights into N6-methyladenosine and programmed cell death in cancer

10.1186/s12943-022-01508-w · 2022 · External reference

Loss of NLN suppresses lung cancer progression by inducing ferroptosis through downregulating m(6)A methylation of GPX4

10.1016/j.redox.2025.103928 · External reference

SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer

10.1038/s41388-025-03426-9 · External reference

The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function

10.1016/j.redox.2020.101801 · External reference

Targeting SLC3A2 subunit of system X(C)(-) is essential for m(6)A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma

10.1016/j.freeradbiomed.2021.03.023 · External reference

DHODH-Mediated ferroptosis defence is a targetable vulnerability in cancer

10.1038/s41586-021-03539-7 · 2021 · External reference

Exploiting metabolic cell death for cancer therapy

10.1038/s41568-025-00879-8 · 2026 · External reference

Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4

10.1038/s41419-024-06963-5 · 2024 · External reference

Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons

10.1016/j.cell.2012.05.003 · 2012 · External reference

Recommendations for robust and reproducible research on ferroptosis

10.1038/s41580-025-00843-2 · 2025 · External reference

Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression

10.1186/s13046-024-03032-9 · 2024 · External reference

PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer

10.1038/s41388-025-03457-2 · 2025 · External reference

METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification

10.1186/s13062-024-00511-z · 2024 · External reference

The interplay of N6-Methyladenosine and ferroptosis in cancer: a promising therapeutic avenue

10.1016/j.cancergen.2025.05.007 · 2025 · External reference

Dynamic RNA modifications in gene expression regulation

10.1016/j.cell.2017.05.045 · 2017 · External reference

RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy

10.1186/s12943-024-02132-6 · 2024 · External reference

Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis

10.1016/j.lfs.2021.119399 · 2021 · External reference

RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m(6)A-dependent manner

10.1038/s41419-022-04524-2 · 2022 · External reference

IDO1 inhibits ferroptosis by regulating FTO-Mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression

10.1038/s41420-025-02293-3 · 2025 · External reference

Decoding ferroptosis for cancer therapy

10.1038/s41568-025-00864-1 · 2025 · External reference

N6-methyladenosine-dependent regulation of messenger RNA stability

10.1038/nature12730 · 2014 · External reference

Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer

10.1186/s13020-023-00820-x · External reference

m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation

10.1007/s10495-023-01817-5 · External reference

FTO sensitizes oral squamous cell carcinoma to ferroptosis via suppressing ACSL3 and GPX4

10.3390/ijms242216339 · External reference

Benzo(a)pyrene promotes the malignant progression of malignant-transformed BEAS-2B cells by regulating YTH N6-methyladenosine RNA binding protein 1 to inhibit ferroptosis

10.1016/j.tox.2024.153886 · 2024 · External reference

10.1097/cm9.0000000000003744 · 2025 · Admitted local publication

Methyltransferase-like 3/14-mediated m(6)A silencing of GPx3 drives lipophagy dysfunction and ferroptosis resistance in colorectal cancer

10.34133/research.1273 · 2026 · External reference

RNA modifications in cancer

10.1002/mco2.70042 · 2025 · External reference

Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer

10.1038/s41419-023-05880-3 · 2023 · External reference

METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification

10.1186/s12935-021-02433-6 · 2022 · External reference

Neutrophil extracellular traps promote growth of lung adenocarcinoma by mediating the stability of m6A-mediated SLC2A3 mRNA-induced ferroptosis resistance and CD8(+) T cell inhibition

10.1002/ctm2.70192 · 2025 · External reference

Regulation of ferroptotic cancer cell death by GPX4

10.1016/j.cell.2013.12.010 · 2014 · External reference

Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer

10.1016/j.jare.2021.10.001 · 2022 · External reference

TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis

10.1038/s41420-023-01727-0 · 2023 · External reference

LncRNA AC040169.1 is regulated by m6A modification and suppresses ferroptosis via SLC7A11 to promote ovarian cancer progression

10.1186/s13048-025-01922-w · External reference

EF24 targets METTL3 to reprogram m6A methylation and induce ferroptosis: an epitranscriptomic mechanism with therapeutical potential for glioma

10.1186/s12964-025-02583-4 · External reference

YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer

10.1038/s41418-023-01234-w · 2023 · External reference

circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain

10.1016/j.ijbiomac.2025.149699 · 2026 · External reference

Reading, writing and erasing mRNA methylation

10.1038/s41580-019-0168-5 · 2019 · External reference

Targeting AKT induced ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer

10.1038/s41420-023-01746-x · 2023 · External reference

METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression

10.1038/s41419-024-07317-x · 2025 · External reference

METTL3-mediated m(6)A modification contributes to anlotinib resistance in osteosarcoma by regulating ferroptosis via the circFAM120B/miR-330-3p/PRKDC axis

10.1016/j.freeradbiomed.2026.03.046 · 2026 · External reference

METTL16 suppresses ferroptosis in cholangiocarcinoma by promoting ATF4 via m(6)A modification

10.7150/ijbs.97886 · 2025 · External reference

ALKBH5 is a Mammalian RNA demethylase that impacts RNA metabolism and mouse fertility

10.1016/j.molcel.2012.10.015 · 2013 · External reference

Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m(6)A-dependent recognition of Nrf2 mRNA mediated by SND1

10.1186/s13046-023-02684-3 · 2023 · External reference

Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies

10.1038/s41392-024-01769-5 · External reference

Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis

10.1186/s13045-024-01545-6 · External reference

GDNF-AS1 mediated LHX2/METTL3/NCOA4 axis inhibits glioma progression via induction of ferroptosis

10.1016/j.neuint.2025.106085 · 2026 · External reference

N6-methyladenosine modification of LATS2 promotes hepatoblastoma progression by inhibiting ferroptosis through the YAP1/ATF4/PSAT1 axis

10.7150/ijbs.92413 · 2024 · External reference

Histone lactylation-mediated up-regulation of IGF2BP2 enhances ferroptosis resistance via Nrf2 in colorectal cancer

10.1002/ctm2.70551 · External reference

PARK7-driven IGF2BP3-K76 lactylation mediates ferroptosis and HAIC resistance in hepatocellular carcinoma

10.1016/j.redox.2025.103869 · External reference

WTAP-mediated glutaminase splicing bias suppresses ferroptosis in hepatocellular carcinoma

10.34133/cancomm.0005 · 2026 · External reference

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

10.1038/s41467-022-30217-7 · 2022 · External reference